Development of drugs based on research by university technology
transfer companies and other researchers.
Employees: 12
Overview
Founded in May 2003 by leading institutions in the Israeli
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
Life-Sciences sector, BioLineRx is a specialized drug development
company, dedicated to bridging the gap between innovative
life-sciences research and clinical drug development and
marketing.
An explosion of Israeli biomedical research has resulted in an
abundance of new drug opportunities that represent tremendous
untapped potential for companies that can effectively develop and
market these drugs. At the same time, however, multi-national
pharmaceutical companies have experienced a severe productivity
crisis, with more money spent every year on R&D and fewer drugs
reaching the world markets. BioLineRx's expert drug development
team in-licenses promising compounds and technologies from
leading academic institutions and biotech companies, and manages
their development from feasibility through Phase 2 clinical
trials, in order to build a pipeline of new drug candidates for
out-licensing to global pharmaceutical marketers.
The BioLineRx founders represent leaders in the Israeli
Life-Sciences sector. BioLineRx's founding partners are Teva
Pharmaceuticals, a global pharmaceutical company, Giza and
Pitango, two of Israel's most successful venture capital funds,
Hadasit, the research and development company of Hadassah
University Hospital, and the Jerusalem Development Authority.
